Personal Information
Entreprise/Lieu de travail
Groningen Area, Netherlands Netherlands
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.lmmi.nl
À propos
Dr. John W. A. Rossen has a 25 year history in molecular microbiology. He is PI in the research group “Genomics for Infection Prevention” of Prof. dr. Alexander Friedrich and head of the (non-viral) molecular unit which has recently implemented the use of next generation sequencing for routine clinical microbiology and infection prevention. The method is used to determine the genetic relationship between pathogens (used to guide infection prevention measures) and for the molecular detection and further characterisation of (emerging) pathogens. This includes analyses for revealing (new) antibiotic resistance mechanisms and for determining the virulence of pathogens resulting in improved r
Mots-clés
sars-cov-2
history
lecture
covid-19
coronavirus
pandemic
pathogenesis
antibody dependent enhancement
molecular biology
covid19
antiviral
vaccine
transmission
immune response
disease
Tout plus
Présentations
(6)Personal Information
Entreprise/Lieu de travail
Groningen Area, Netherlands Netherlands
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
www.lmmi.nl
À propos
Dr. John W. A. Rossen has a 25 year history in molecular microbiology. He is PI in the research group “Genomics for Infection Prevention” of Prof. dr. Alexander Friedrich and head of the (non-viral) molecular unit which has recently implemented the use of next generation sequencing for routine clinical microbiology and infection prevention. The method is used to determine the genetic relationship between pathogens (used to guide infection prevention measures) and for the molecular detection and further characterisation of (emerging) pathogens. This includes analyses for revealing (new) antibiotic resistance mechanisms and for determining the virulence of pathogens resulting in improved r
Mots-clés
sars-cov-2
history
lecture
covid-19
coronavirus
pandemic
pathogenesis
antibody dependent enhancement
molecular biology
covid19
antiviral
vaccine
transmission
immune response
disease
Tout plus